<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Pepg on Finance Insights Daily</title><link>https://finance.dpfeed.com/tags/pepg/</link><description>Recent content in Pepg on Finance Insights Daily</description><image><title>Finance Insights Daily</title><url>https://finance.dpfeed.com/images/finance-insights-og.jpg</url><link>https://finance.dpfeed.com/images/finance-insights-og.jpg</link></image><generator>Hugo -- 0.147.7</generator><language>en-us</language><lastBuildDate>Tue, 31 Mar 2026 06:43:42 +0000</lastBuildDate><atom:link href="https://finance.dpfeed.com/tags/pepg/index.xml" rel="self" type="application/rss+xml"/><item><title>FREEDOM2: PEPG's Lowest Dose Shows Promising Safety and Efficacy.</title><link>https://finance.dpfeed.com/posts/freedom2-pepg-s-lowest-dose-shows-promising-safety-and-efficacy/</link><pubDate>Tue, 31 Mar 2026 06:43:42 +0000</pubDate><guid>https://finance.dpfeed.com/posts/freedom2-pepg-s-lowest-dose-shows-promising-safety-and-efficacy/</guid><description>Financial analysis and investment insights on PepGen Inc. (PEPG) Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable</description></item></channel></rss>